Disease Management Clinical Decisions - Menopause and Hormone Therapy

Disease Management Clinical Decisions - Menopause and Hormone Therapy is organized by Cleveland Clinic Center for Continuing Education.

Release date: March 07, 2024
Expiration date: March 06, 2027

Description:
Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.

Learning Objectives
After completing this case the reader should be able to:
• Perform a postmenopausal risk assessment that includes vasomotor symptoms, symptoms of genitourinary syndrome of menopause, and osteoporosis in estrogen-deficient postmenopausal women.
• Appropriately select hormone therapy, particularly estrogen-alone therapy, for postmenopausal women without a uterus.
• Counsel postmenopausal women regarding the risks and benefits of, and alternatives to, hormone therapy.
• Summarize changes in the updated North American Menopause Society guidelines on menopause, especially regarding hormone therapy.
• Describe the effectiveness of hormone therapy for vasomotor symptoms and symptoms of the genitourinary syndrome of menopause, as well as for bone loss and fracture prevention.